Sequencing

News on NGS technologies, RNA-seq, clinical sequencing, & sample prep in genetics, genomics, and molecular diagnostics.

Sep 13, 2022

GenDx, Oxford Nanopore Technologies Sign Service Agreement for HLA Typing Assay

Sep 13, 2022

Pediatric Patients Face Barriers Receiving Exome Sequencing From Insurance, Scheduling Delays
Premium

Sep 6, 2022

Genes2Me Signs European Distribution Deal With Axonlab

Sep 6, 2022

EU to Disallow Illumina's Grail Purchase

Sep 2, 2022

BGI Gets CE-IVD Mark for Thalassemia Test

Sep 1, 2022

Illumina Says Judge Issued Favorable Decision in FTC Challenge to Grail Acquisition

Sep 1, 2022

DOJ Charges Florida Lab Owner in $53M Genetic Testing Fraud Scheme

Aug 30, 2022

Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software

Aug 29, 2022

Genome Insight, Ajou University Medical Center to Test WGS Use for Routine Cancer Care

Aug 23, 2022

Biotia Raises $8M in Series A Financing

Aug 22, 2022

MDIC Launches Initiative to Improve Accuracy of Next-Generation Sequencing-Based Cancer Diagnostics

Aug 22, 2022

Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay

Aug 18, 2022

Personalis Adds Newly Issued Patent to Foresight Diagnostics Infringement Suit

Aug 17, 2022

Eurobio Scientific to Acquire GenDx for €135M in Cash

Aug 9, 2022

Predicine Receives CE-IVD Mark for Blood and Urine Liquid Biopsy Assay

Aug 8, 2022

CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection
Premium

Aug 5, 2022

Myriad Q2 Revenues Down 5 Percent, GeneSight PGx Business Shows Strong Growth
Premium

Aug 4, 2022

Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth
Premium

Aug 3, 2022

New Nanopore Sequencing Method Enables Direct Poliovirus Detection
Premium

Aug 2, 2022

Personalis Sues Foresight Diagnostics, Alleging Patent Infringement